Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, with a share price of HKD 88, representing a rise of over 13.15%, and a total market capitalization of approximately HKD 12.29 billion [1] Group 1: Company Performance - Lin Qingxuan focuses on the anti-wrinkle and firming skincare industry, providing high-end skincare solutions with natural camellia ingredients [1] - Revenue is projected to grow from CNY 691 million in 2022 to CNY 1.21 billion in 2024, reflecting a compound annual growth rate (CAGR) of 32.3% [1] - In the first half of 2025, revenue is expected to increase by 98.3% to CNY 1.05 billion compared to CNY 530 million in the same period of 2024; adjusted net profit is anticipated to rise from CNY 92 million to CNY 200 million, a year-on-year increase of 117.4% [1] Group 2: Future Strategy - The founder, Sun Laichun, stated the company will continue to invest in research and development in dermatology, botany, and cutting-edge skincare technology [1] - There will be an emphasis on brand building and retail store expansion, alongside upgrading popular products such as camellia oil, golden pearl essence, and black gold cream to enhance customer skincare experiences and create higher value for shareholders [1]
林清轩上市首日市值超122.9亿港元，上半年营收增长98.3%